NCT05597085 A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment Status COMPLETED Phase N/A
NCT05596734 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza Status COMPLETED Phase PHASE2
NCT05588310 Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated Factors Status UNKNOWN Phase N/A
NCT05584644 A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer Status COMPLETED Phase N/A
NCT05583526 A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo Status COMPLETED Phase PHASE3
NCT05580003 A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People Status COMPLETED Phase PHASE1
NCT05579977 Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity Status TERMINATED Phase PHASE2
NCT05579847 Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy Status COMPLETED Phase N/A
NCT05577819 Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF Status RECRUITING Phase NA
NCT05576051 To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting. Status COMPLETED Phase N/A
NCT05574010 A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) Status TERMINATED Phase PHASE1/PHASE2
NCT05573555 TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05572567 Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT05572450 Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain Status COMPLETED Phase NA
NCT05569928 In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects Status UNKNOWN Phase NA
NCT05568719 Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively Status RECRUITING Phase PHASE3
NCT05568407 A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer Status TERMINATED Phase N/A
NCT05567952 A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir Status COMPLETED Phase PHASE2